Latest Morning Briefing Stories

KHN’s ‘What the Health?’: Our 200th Episode!

KFF Health News Original

The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.

No-Cancel Culture: How Telehealth Is Making It Easier to Keep That Therapy Session

KFF Health News Original

No-shows for behavioral health appointments have been a long-standing problem, with up to 60% skipped. Now telehealth, fueled by the pandemic, makes it easier for people dealing with depression and other mental health issues to make it to their appointments at a time when such care is in high demand. But teletherapy creates other challenges.